Please select the option that best describes you:
Topics:
Radiation Oncology • Gastrointestinal Cancers • Medical Oncology • Liver and Pancreas Tumors • Internal Medicine • Hepatocellular Carcinoma • Gastroenterology • Journal Club ft. NEJM publications • General Hepatology
Would you use upfront atezo/bev in a patient with HCC and untreated hepatitis?
Answer from: Medical Oncologist at Community Practice
Yes. I would not have concerns. For HBV, I would start treatment before or simultaneously. Studies have varied by protocol about the HBV viral load being under 500 or 100 but it is not clear this matters. There have not been flairs reported. In regards to HCV, again, not an issue f...
Sign in or Register to read more
Answer from: Medical Oncologist at Academic Institution
In the case of a patient with untreated chronic hepatitis C, I would offer upfront atezo/bev, as long as hepatic function is appropriate. At our center, hepatitis C treatment is generally not offered to patients with advanced HCC. Interestingly, only 21% of patients treated with atezolizu...
Answer from: Medical Oncologist at Academic Institution
Patients with hepatitis B should be on antiviral therapy with HBV DNA level of 500 or less; all trials with immune checkpoint inhibitors have had such a requirement. There are no limitations or special requirements in regards to treatment of Patients for hepatitis C prior to initiation of hepatitis ...